3D Bioprinting Market Expanding At A CAGR Of 19.5% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.
San Francisco, 26 July 2019: The Report 3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based), By Application (Medical, Dental, Biosensors, Bioinks), And Segment Forecasts, 2019 – 2026 The global 3D bioprinting market size is expected to reach USD 4.1 billion by 2026 registering a CAGR of 19.5%, according to a new report by Grand View Research, Inc. Growing usage of 3D printing in cosmetic surgeries and innovations in the 3D bioprinting are expected to propel the market growth over the forecast period. The technology is commonly used to print prosthetics and dental accessories, medical devices, and bone implants. The medical application segment is projected to expand at a significant pace, as the technology has the potential to reduce the drug development costs. For instance, in March 2016, a U.S.-based specialty pharmaceutical firm became the world’s first company to receive approval from